Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01258855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

NIH

Sponsor class

Conditions

Metastatic Melanoma
Recurrent Melanoma
Stage III Cutaneous Melanoma AJCC v7
Stage IIIA Cutaneous Melanoma AJCC v7
Stage IIIB Cutaneous Melanoma AJCC v7
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7

Interventions

BIOLOGICAL: Aldesleukin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Ziv-Aflibercept

Sponsor

National Cancer Institute (NCI)